BIOR - BIORA THERAPEUTICS, INC.
IEX Last Trade
0.5461
-0.214 -39.169%
Share volume: 0
Last Updated: Tue 10 Dec 2024 09:29:11 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
3.82%
PREVIOUS CLOSE
CHG
CHG%
$0.76
-0.21
-28.14%
Fundamental analysis
32%
Profitability
49%
Dept financing
31%
Liquidity
12%
Performance
20%
Performance
5 Days
0 0%
1 Month
-67.08%
3 Months
-0.94%
6 Months
-17.69%
1 Year
-56.27%
2 Year
252.01%
Key data
Stock price
$0.55
DAY RANGE
$0.65 - $0.74
52 WEEK RANGE
$0.51 - $5.69
52 WEEK CHANGE
-$57.92
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/11/2024
Company detail
CEO: Aditya P. Mohanty
Region: US
Website: bioratherapeutics.com
Employees: 120
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: bioratherapeutics.com
Employees: 120
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.
Recent news